Reactivation of adult-onset Still’s disease after use of the COVID-19 ChAdOx1-S vaccine

A woman in her 60s with a history of adult-onset Still’s disease (AOSD) in remission for 14 years received the ChAdOx1-S vaccine as a booster to her initial vaccination schedule (two doses of CoronaVac vaccine 6 months apart). Two weeks later, she consulted for symptoms suggestive of AOSD reactivati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibáñez Vodnizza, Sebastián E, Morales Murillo, Luis, de la Rivera Vergara, Matías, Saldías Martínez, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Reports: Adverse drug reactions and complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422839/
https://www.ncbi.nlm.nih.gov/pubmed/36028238
http://dx.doi.org/10.1136/bcr-2022-249290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422839/
https://www.ncbi.nlm.nih.gov/pubmed/36028238
http://dx.doi.org/10.1136/bcr-2022-249290

Ejemplares similares